LIFECORE BIOMEDICAL, INC. Proceeds from Collection of Notes Receivable
LIFECORE BIOMEDICAL, INC. (LFCR) had Proceeds from Collection of Notes Receivable of $4.00 million as of 2026-01-07, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2021-05-30 was $0.00.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2021-02-28 was $0.00.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2020-11-29 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2020-08-30 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for fiscal 2022 was $0.00.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for fiscal 2020 was $364.00K, a 33.21% decline from fiscal 2019.
- LIFECORE BIOMEDICAL, INC. proceeds from collection of notes receivable for fiscal 2019 was $545.00K.
| Period end | Proceeds from Collection of Notes Receivable | Proceeds from Collection of Notes Receivable 1 month | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-01-07 | $4.00M 10-Q · filed 2026-08-05 | |||||
| 2025-07-07 | $4.00M 10-Q · filed 2026-08-05 | |||||
| 2024-02-25 | $900.00K 10-Q · filed 2024-08-09 | |||||
| 2022-05-29 | $0.00 10-K/A · filed 2023-03-16 | |||||
| 2021-05-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 10-K/A · filed 2023-03-16 | ||
| 2021-02-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $0.00 derived: sum of 2 quarters · filed 2021-04-08 | $0.00 10-Q · filed 2021-04-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-11-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $0.00 10-Q · filed 2021-01-07 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $0.00 derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-08-30 | $0.00 10-Q · filed 2020-10-07 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $0.00 derived: sum of 3 quarters · filed 2023-03-16 | $68.00K derived: sum of 4 quarters · filed 2023-03-16 | ||
| 2020-05-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-16 | $68.00K derived: sum of 3 quarters · filed 2023-03-16 | $364.00K 10-K/A · filed 2023-03-16 | ||
| 2020-02-23 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $68.00K derived: sum of 2 quarters · filed 2021-04-08 | $364.00K 10-Q · filed 2021-04-08 | $505.00K derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-11-24 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $364.00K 10-Q · filed 2021-01-07 | $505.00K derived: sum of 3 quarters · filed 2021-07-29 | $714.00K derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-08-25 | $296.00K 10-Q · filed 2020-10-07 | $437.00K derived: sum of 2 quarters · filed 2021-07-29 | $646.00K derived: sum of 3 quarters · filed 2021-07-29 | $841.00K derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-05-26 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $350.00K derived: sum of 2 quarters · filed 2021-07-29 | $545.00K derived: sum of 3 quarters · filed 2021-07-29 | $545.00K 10-K · filed 2021-07-29 | ||
| 2019-02-24 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $404.00K derived: sum of 2 quarters · filed 2020-04-03 | $404.00K 10-Q · filed 2020-04-03 | $404.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-11-25 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $195.00K 10-Q · filed 2020-01-02 | $195.00K derived: sum of 3 quarters · filed 2020-08-14 | |||
| 2018-08-26 | $0.00 10-Q · filed 2019-10-03 | $0.00 derived: sum of 2 quarters · filed 2020-08-14 | ||||
| 2018-05-27 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $0.00 10-K · filed 2020-08-14 | ||||
| 2018-02-25 | $0.00 10-Q · filed 2019-04-04 | |||||
| 2017-05-28 | $0.00 10-K · filed 2019-08-01 | |||||
| 2016-02-28 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $482.00K 10-Q · filed 2016-03-30 | ||||
| 2015-11-29 | $249.00K 10-Q · filed 2016-01-07 | |||||
| 2015-05-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $5.37M derived: sum of 2 quarters · filed 2016-03-30 | $5.47M derived: sum of 3 quarters · filed 2016-03-30 | $5.73M 10-K · filed 2015-07-31 | ||
| 2015-03-01 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $4.47M derived: sum of 2 quarters · filed 2016-03-30 | $4.73M 10-Q · filed 2016-03-30 | |||
| 2014-11-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $363.00K 10-Q · filed 2016-01-07 | ||||
| 2014-08-31 | $255.00K 10-Q · filed 2014-10-08 | |||||
| 2014-05-25 | $4.48M 10-K · filed 2015-07-31 | |||||
| 2013-05-26 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $4.17M 10-K · filed 2015-07-31 | ||||
| 2013-02-24 | $3.59M 10-Q · filed 2013-04-04 | |||||
| 2012-05-27 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $3.46M derived: sum of 2 quarters · filed 2014-08-01 | $3.70M derived: sum of 3 quarters · filed 2014-08-01 | $3.70M 10-K · filed 2014-08-01 | ||
| 2012-02-26 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $3.19M derived: sum of 2 quarters · filed 2013-04-04 | $3.20M 10-Q · filed 2013-04-04 | $3.39M derived: sum of 4 quarters · filed 2013-08-07 | ||
| 2011-11-27 | $235.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $240.00K 10-Q · filed 2013-01-04 | $436.00K derived: sum of 3 quarters · filed 2013-08-07 | |||
| 2011-08-28 | $5.00K 10-Q/A · filed 2013-01-02 | $201.00K derived: sum of 2 quarters · filed 2013-08-07 | ||||
| 2011-05-29 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $3.31M 10-K · filed 2013-08-07 | ||||
| 2011-02-27 | $3.12M 10-Q · filed 2012-03-28 | |||||
| 2010-11-28 | $637.00K 10-Q · filed 2012-01-05 | |||||
| 2010-08-29 | $314.00K 10-Q · filed 2011-10-05 | |||||
| 2010-05-30 | $2.98M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |